-
Grandall Assisted Bank of Gansu Boarding HKEx
-
Grandall Assisted HYBIO Pharmaceutical in Issuing Corporate Bonds
-
Grandall Assisted Secote Boarding Shanghai Stock Exchange
-
Grandall Advised eHi’s Issue of USD 400M Bonds Abroad
-
Grandall Advised Industrial Bank in its Non-public Offering
-
Grandall Advised China National Medicines in its Reorganization 19 January 2017
-
Grandall Advised CFFE, SSE and SZSE in the Investment in Pakistan Stock Exchange
-
Grandall Advised DZUG’s Global Offering on HK Market
-
Grandall Advised Dalian Rongqiang Investment in the Issue of Corporate Bonds
-
Grandall Advised Fosun Pharma in A-share Non-public Offering
-
Grandall Shanghai Office Advised Ningbo Joyson for Its M&A Project
-
Shanghai Yuyuan’s Non-public Offering Approved, Grandall Shanghai Office Retained as the Issuer’s Counsel
-
Grandall Hangzhou Office Advised Hangzhou Ontime’s NEEQ Listing
-
Grandall Chengdu Office Advised Sichuan KLT ’s NEEQ Listing
-
Grandall Advised the 1st Asset-Backed Program under CIRC’s Newly Released Policy
-
Grandall Advised Shanghai Jinjiang for its Acquisition Project of Plateno Hotels Group
-
Grandall Advised Shanghai New World for its Non-public Offering Project
-
Shanghai Juneyao Airlines’ Non-public Offering Approved, Grandall Shanghai Office Retained as the Issuer’s Counsel
-
HC SemiTek’s Material Asset Reorganization Approved by CSRC, Grandall Shanghai Office Acted as Legal Counsel
-
Grandall Beijing Office Advised China Nonferrous Metal Mining’s Offering of US$ 500 Million External Debts